Shinya Sakata

1.6k total citations
71 papers, 722 citations indexed

About

Shinya Sakata is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Nuclear and High Energy Physics. According to data from OpenAlex, Shinya Sakata has authored 71 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 11 papers in Nuclear and High Energy Physics. Recurrent topics in Shinya Sakata's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (16 papers) and Magnetic confinement fusion research (11 papers). Shinya Sakata is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (16 papers) and Magnetic confinement fusion research (11 papers). Shinya Sakata collaborates with scholars based in Japan, United States and Germany. Shinya Sakata's co-authors include Sho Saeki, Yusuke Tomita, Koichi Saruwatari, Takuro Sakagami, Takayuki Jodai, Shinji Iyama, Tokunori Ikeda, Kimitaka Akaike, Shiho Ishizuka and Ryo Sato and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Shinya Sakata

60 papers receiving 712 citations

Peers

Shinya Sakata
Xue‐Jun Guo China
Muhammad Irfan Pakistan
Xiongfei Yu China
John W. C. Chang Taiwan
Hartmut Schaefer Germany
Christine Yip United States
Ruoxi Yu United States
Aimin Jiang China
Bojiang Chen China
Veera Baladandayuthapani United States
Xue‐Jun Guo China
Shinya Sakata
Citations per year, relative to Shinya Sakata Shinya Sakata (= 1×) peers Xue‐Jun Guo

Countries citing papers authored by Shinya Sakata

Since Specialization
Citations

This map shows the geographic impact of Shinya Sakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinya Sakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinya Sakata more than expected).

Fields of papers citing papers by Shinya Sakata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinya Sakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinya Sakata. The network helps show where Shinya Sakata may publish in the future.

Co-authorship network of co-authors of Shinya Sakata

This figure shows the co-authorship network connecting the top 25 collaborators of Shinya Sakata. A scholar is included among the top collaborators of Shinya Sakata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinya Sakata. Shinya Sakata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujimoto, Daichi, Ryota Shibaki, Keiichi Kimura, et al.. (2025). Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning. Lung Cancer. 199. 108079–108079. 1 indexed citations
2.
Saruwatari, Koichi, Seitaro Oda, Shinya Shiraishi, et al.. (2024). Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer. Respiratory Investigation. 62(6). 1072–1078.
3.
Yoshioka, Hiroshige, Hiroaki Akamatsu, Shinya Sakata, et al.. (2024). Final analysis of SCARLET study: A single-arm, phase II study of sotorasib plus carboplatin-pemetrexed in patients with advanced non-squamous, non-small cell lung cancer KRAS G12C mutation.. Journal of Clinical Oncology. 42(16_suppl). 8616–8616. 2 indexed citations
4.
Saruwatari, Koichi, Kosuke Fujino, Takayuki Jodai, et al.. (2024). Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation. Journal of Thoracic Disease. 16(2). 1151–1160.
5.
Miyawaki, Taichi, Hirotsugu Kenmotsu, Hideyuki Harada, et al.. (2021). Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L). BMC Cancer. 21(1). 1121–1121. 5 indexed citations
6.
Ito, Kentaro, Shinya Sakata, Kohei Otsubo, et al.. (2021). MO4-5 A multicenter retrospective study of Oncomine Dx Target Test multi-CDx system for genetic profiling of NSCLC: WJOG13019L. Annals of Oncology. 32. S297–S297. 1 indexed citations
7.
Hayashi, Hidetoshi, Kimio Yonesaka, Shunichi Sugawara, et al.. (2021). FP14.16 Phase 2 Trial of the Alternating Therapy with Osimertinib and Afatinib for Treatment-Naive Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer (WJOG10818L/Alt Trial). Journal of Thoracic Oncology. 16(3). S234–S235. 1 indexed citations
8.
Sakata, Shinya, Shinji Iyama, Kentaro Tokunaga, et al.. (2021). Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics. Critical Care. 25(1). 59–59. 7 indexed citations
9.
Tomita, Yusuke, Tokunori Ikeda, Shinya Sakata, et al.. (2020). Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer. Cancer Immunology Research. 8(10). 1236–1242. 161 indexed citations
10.
Sakata, Shinya, Kazuyoshi Nakamura, Hiroko Okabayashi, et al.. (2019). Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin. Internal Medicine. 58(9). 1329–1333.
11.
Watanabe, Satomi, Takeharu Yamanaka, Kentaro Ito, et al.. (2019). OA02.06 The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L). Journal of Thoracic Oncology. 14(10). S209–S210. 1 indexed citations
12.
Sakata, Shinya, et al.. (2018). Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a <i>HER2</i>-mutation. Internal Medicine. 57(15). 2223–2226. 2 indexed citations
13.
14.
Ishizuka, Shiho, Shinya Sakata, Akira Takaki, et al.. (2018). Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression. Respiratory Investigation. 56(4). 361–364. 16 indexed citations
15.
Sakata, Shinya, Sho Saeki, Ryo Sato, et al.. (2017). Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma. Respiratory Investigation. 55(6). 372–375. 5 indexed citations
16.
Sakata, Shinya, Sho Saeki, Isamu Okamoto, et al.. (2016). Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301. Lung Cancer. 99. 41–45. 22 indexed citations
17.
Ozeki, T., Y. Suzuki, Shinya Sakata, et al.. (2009). Development and Demonstration of Remote Experiment System with High Security in JT-60U. Max Planck Institute for Plasma Physics. 3 indexed citations
18.
Oshima, Taku, et al.. (2007). Improvement of data processing system for advanced diagnostics in JT-60U. Fusion Engineering and Design. 82(5-14). 1210–1215. 1 indexed citations
19.
Kurihara, Kenichi, et al.. (1990). Tokamak plasma shape identification with a Legendre-Fourier expansion of the vacuum poloidal flux function in the toroidal coordinates. Unknow. 1 indexed citations
20.
Baba, Takehiko, M. Fukui, Shinya Sakata, et al.. (1989). Selective enhancement of intratumoural blood flow in malignant gliomas: Experimental study in rats by intracarotid administration of adenosine or adenosine triphosphate. Acta Neurochirurgica. 101(1-2). 66–74. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue‐Jun Guo Breakdown of academic impact, for papers by Muhammad Irfan Breakdown of academic impact, for papers by Xiongfei Yu Breakdown of academic impact, for papers by John W. C. Chang Breakdown of academic impact, for papers by Hartmut Schaefer Breakdown of academic impact, for papers by Christine Yip Breakdown of academic impact, for papers by Ruoxi Yu Breakdown of academic impact, for papers by Aimin Jiang Breakdown of academic impact, for papers by Bojiang Chen Breakdown of academic impact, for papers by Veera Baladandayuthapani
Rankless by CCL
2026